Skip to main content
Equibles

TUDOR INVESTMENT CORP ET AL

Position in RNA — Atrium Therapeutics, Inc.

CIK 923093 STAMFORD, CT
Back to RNA Full portfolio

Position in RNA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,742,998
+$788,929 QoQ
Shares Held
129,591
+81.6% QoQ
Ownership
0.758%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#27
of 154 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in RNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $414,135,114 across 107 Biotechnology names. RNA ranks #40 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
 943,287 $66,643,226
2 RPRX
Royalty Pharma plc
 610,736 $34,243,967
3 XENE
Xenon Pharmaceuticals Inc.
 545,387 $32,919,559
4 ABVX
Abivax S.A.
 187,335 $24,964,262
5 INSM
INSMED Inc
 195,391 $20,832,588
6 MLYS
Mineralys Therapeutics, Inc.
 738,370 $19,921,222
7 ABCL
AbCellera Biologics Inc.
 2,063,191 $16,196,049
8 QURE
uniQure N.V.
 328,889 $15,148,627

All Filings in RNA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,742,998 129,591
2026-03-31 $954,069 71,359